Genome Research Attend a BioResearch Product Faire

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Cao, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Cao, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Vol. 10, Issue 5, 652-658, May 2000

LETTER
Association Between Nuclear Lamin A/C R482Q Mutation and Partial Lipodystrophy with Hyperinsulinemia, Dyslipidemia, Hypertension, and Diabetes

Robert A. Hegele,1 Carol M. Anderson, Jian Wang, Doreen C. Jones, and Henian Cao

Robarts Research Institute, London, Ontario, Canada N6A 5K8

Nuclear lamins A and C are encoded by LMNA and are present in terminally differentiated cells. Lamins participate in DNA replication, chromatin organization, arrangement of nuclear pores, nuclear growth, and anchorage of nuclear membranes. In several Canadian probands with partial lipodystrophy, since found to have a common ancestor, we identified a rare novel LMNA mutation, R482Q, that completely cosegregated with the partial lipodystrophy phenotype. We evaluated the relationship between quantitative metabolic phenotypes in both diabetic and nondiabetic carriers of LMNA R482Q and family controls, who were LMNA R482/R482 homozygotes. We found that when compared with LMNA R482/R482 homozygotes: (1) diabetic LMNA Q482/R482 heterozygotes had significantly higher glucose, glycosylated hemoglobin, triglycerides, insulin and C-peptide, and significantly lower HDL cholesterol; and (2) nondiabetic LMNA Q482/R482 heterozygotes had significantly higher triglycerides, insulin and C-peptide, and significantly lower HDL cholesterol. We also found that diabetic LMNA Q482/R482 heterozygotes were older and more likely to take antihypertensive medications. Thus, LMNA R482Q was associated with lipodystrophy, hyperinsulinemia, dyslipidemia, diabetes, and hypertension. The results indicate that perturbations in plasma lipids precede the plasma glucose abnormalities in LMNA Q482-associated hyperinsulinemia. Thus, rare mutations in a nuclear structural protein can be associated with markedly abnormal qualitative and quantitative metabolic phenotypes

1 Corresponding author.

10:652-658 ©2000 by Cold Spring Harbor Laboratory Press  ISSN 1088-9051/00 $5.00
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. I. Anghel, E. Bedu, C. D. Vivier, P. Descombes, B. Desvergne, and W. Wahli
Adipose Tissue Integrity as a Prerequisite for Systemic Energy Balance: A CRITICAL ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {gamma}
J. Biol. Chem., October 12, 2007; 282(41): 29946 - 29957.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Ludtke, J. Buettner, W. Wu, A. Muchir, A. Schroeter, S. Zinn-Justin, S. Spuler, H. H.-J. Schmidt, and H. J. Worman
Peroxisome Proliferator-Activated Receptor-{gamma} C190S Mutation Causes Partial Lipodystrophy
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2248 - 2255.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. L. Mesa, R. J.F. Loos, P. W. Franks, K. K. Ong, J. Luan, S. O'Rahilly, N. J. Wareham, and I. Barroso
Lamin A/C Polymorphisms, Type 2 Diabetes, and the Metabolic Syndrome: Case-Control and Quantitative Trait Studies
Diabetes, March 1, 2007; 56(3): 884 - 889.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Hegele and R. L. Pollex
Genetic and physiological insights into the metabolic syndrome
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R663 - R669.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
ABDOMINAL OBESITY STUDY GROUP, F. E. VON EYBEN, J. P. KROUSTRUP, J. F. LARSEN, and J. CELIS
Comparison of Gene Expression in Intra-Abdominal and Subcutaneous Fat: A Study of Men with Morbid Obesity and Nonobese Men Using Microarray and Proteomics
Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 508 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
N. I. Steinle, R. Kazlauskaite, I. G. Imumorin, W.-C. Hsueh, T. I. Pollin, J. R. O'Connell, B. D. Mitchell, and A. R. Shuldiner
Variation in the Lamin A/C Gene: Associations With Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1708 - 1713.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. Z. Al-Shali and R. A. Hegele
Laminopathies and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1591 - 1595.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. L. Herbst, L. R. Tannock, S. S. Deeb, J. Q. Purnell, J. D. Brunzell, and A. Chait
Kobberling Type of Familial Partial Lipodystrophy: An underrecognized syndrome
Diabetes Care, June 1, 2003; 26(6): 1819 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Hegele, M. E. Kraw, M. R. Ban, B. A. Miskie, M. W. Huff, and H. Cao
Elevated Serum C-Reactive Protein and Free Fatty Acids Among Nondiabetic Carriers of Missense Mutations in the Gene Encoding Lamin A/C (LMNA) With Partial Lipodystrophy
Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 111 - 116.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. J. Lelliott, L. Logie, C. P. Sewter, D. Berger, P. Jani, F. Blows, S. O'Rahilly, and A. Vidal-Puig
Lamin Expression in Human Adipose Cells in Relation to Anatomical Site and Differentiation State
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 728 - 734.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. H.-J. Schmidt and R. A. Hegele
Consider Cardiomyopathy in Subjects With Familial Partial Lipodystrophy Response
Circulation, January 15, 2002; 105 (2): e7 - e7.
[Full Text] [PDF]

Home page
 CirculationHome page
R. A. Hegele
Premature Atherosclerosis Associated With Monogenic Insulin Resistance
Circulation, May 8, 2001; 103(18): 2225 - 2229.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
V C Blackwell, P Salis, R W Groves, S E Baldeweg, G S Conway, and R J Unwin
Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a common link to insulin resistance?
J R Soc Med, May 1, 2001; 94(5): 238 - 240.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. H.-J. Schmidt, J. Genschel, P. Baier, M. Schmidt, J. Ockenga, U. J. F. Tietge, M. Pröpsting, C. Büttner, M. P. Manns, H. Lochs, et al.
Dyslipemia in Familial Partial Lipodystrophy Caused by an R482W Mutation in the LMNA Gene
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2289 - 2295.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Genes Dev. Learn. Mem.
Protein Science RNA Genome Res.